Evonik Industries AG (Essen; www.evonik.com) and OPX Biotechnologies, Inc. (OPXBio; Boulder, Colo.; www.opxbio.com) have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint development agreement was signed May 3, 2013, and calls for OPXBio to use its proprietary EDGE (efficiently directed genome engineering) technology to develop the bio-processes.
Evonik Industries and OPX Biotechnologies to jointly develop bio-based chemicals
| By Dorothy Lozowski